ABOUT ICRF
THE ANSWER TO CANCER IS RESEARCH
Your support of Israel Cancer Research Fund (ICRF) fuels groundbreaking cancer research led by Israel’s best and brightest scientists—work that is saving lives and improving treatments for patients around the world.
ICRF has proudly funded 2 Nobel laureates and countless distinguished researchers across Israel’s hospitals, universities, and research institutions. To date, more than USD $100,000,000 has been invested in nearly 3,000 cancer research grants.
Join ICRF in advancing lifesaving Israeli cancer research—and help bring us one step closer to a world without cancer.
WHY ICRF?
Your Gift Goes Further
Research in Israel carries less overhead than North American research and funds are allocated directly to our scientists in their labs.
Ongoing Breakthroughs
ICRF has funded 3000 research projects through all cancer fields.
OUR SUCCESSES
Gleevec®
The development of Gleevec (imatinib) marked a turning point in cancer care, transforming chronic myelogenous leukemia into a manageable disease for more than 200,000 people worldwide.
P53 Gene
p53, known as the “guardian of the genome”, stands as one of the most important scientific discoveries of the 20th century, with mutations found in approximately 50% of all human tumors.
The Ubiquitin System
The groundbreaking discovery of the ubiquitin–proteasome system led to Velcade, a transformative treatment for multiple myeloma, and was recognized with the 2004 Nobel Prize in Chemistry.
Doxil®
The first liposomal (fat-encapsulated) chemotherapy agent, offering longer circulation and reduced toxicity. It is now used in treating ovarian cancer, AIDS-related Kaposi’s sarcoma, and other cancers.
